Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.325 CHF | -0.16% | +1.31% | -5.30% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.30% | 117M | |
+10.23% | 9.11B | |
-10.76% | 5.21B | |
+53.60% | 4.83B | |
+7.56% | 4.09B | |
+15.27% | 2.32B | |
-21.42% | 2.35B | |
+25.03% | 2.27B | |
-30.36% | 2.19B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Wins Priority Review for Duchenne Muscular Dystrophy Drug in China